Evidence map›Paper›PMID 30850727›Full record

ArticleScientific reports2019

Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study.

Masanori Abe, Takayuki Hamano, Junichi Hoshino, Atsushi Wada, Shigeru Nakai, Norio Hanafusa, Ikuto Masakane, Kosaku Nitta, Hidetomo Nakamoto

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Value of DUSP6 in peripheral blood mononuclear cells in predicting adverse cardiovascular events after peritoneal dialysis in diabetic nephropathy.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masanori AbeThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan. abe.masanori@nihon-u.ac.jp.ORCID 0000-0002-9156-5415
Takayuki HamanoThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Junichi HoshinoThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.ORCID 0000-0002-0444-101X
Atsushi WadaThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Shigeru NakaiThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Norio HanafusaThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Ikuto MasakaneThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Kosaku NittaThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Hidetomo NakamotoThe Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been no nationwide study of prognostic factors and outcomes in patients on peritoneal dialysis (PD) in Japan. We conducted a cohort study using data from the nationwide registry of the Japanese Society for Dialysis Therapy. We followed 8,954 prevalent PD patients for 2 years, 2014-2015. Cox proportional hazards regression analysis was used to determine factors that were independently associated with patient survival. Survival rates were compared between patients with and without diabetes after adjusting for potential confounders. During the 2-year study period, 893 (10.0%) of 8,954 patients died, 148 (1.6%) underwent kidney transplantation, and 2,637 (29.4%) were switched to hemodialysis; 5,276 (58.9%) patients were alive at the end of the study period. After multivariate adjustment, older age, longer duration of dialysis, presence of diabetes, cardiovascular comorbidity, use of 2.5% glucose dialysate, higher C-reactive protein and phosphate levels, and a lower serum albumin level were independently associated with increased hazard ratios for all-cause mortality. A combination of PD and hemodialysis was associated with a lower mortality rate. The new-onset cardiovascular event rate was significantly higher in the diabetes group than in the non-diabetes group (P < 0.0001). After adjusting for all variables, the hazard ratio was 1.509 (95% confidence interval 1.029-2.189, P = 0.036) in the diabetes group. Diabetes, older age, longer duration of dialysis, cardiovascular comorbidity, and inflammation were predictors of mortality in patients on PD.

Indexed as

Cohort StudiesC-Reactive ProteinFemaleHumansJapanKidney TransplantationMaleMiddle AgedPeritoneal DialysisProportional Hazards ModelsRegistriesRegression AnalysisSurvival RateTime FactorsTreatment OutcomeC-Reactive Protein

Identifiers

PMID30850727
PMCPMC6408436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.